• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

接受长期腹膜透析的儿童金黄色葡萄球菌鼻腔携带情况。

Staphylococcus aureus nasal carriage in children receiving long-term peritoneal dialysis.

作者信息

Kingwatanakul P, Warady B A

机构信息

Children's Mercy Hospital, Kansas City, Missouri, USA.

出版信息

Adv Perit Dial. 1997;13:281-4.

PMID:9360700
Abstract

The frequency of Staphylococcus aureus (SA) nasal carriage and the impact of antibiotic therapy remain undefined in children receiving long-term peritoneal dialysis (PD). We obtained a nasal culture for SA every 4-12 weeks in 21 children (mean age 7.03 +/- 5.8 years) receiving PD from January 1992 to August 1996 (total of 35.3 patient-years). In each case, SA nasal carriage (NSA+) was treated with intranasal mupirocin for 7 days. NSA+ was detected in 13 patients (61.9%) who received dialysis for 28.9 patient-years. Eight (61.5%) of 13 patients became NSA+ during the initial 3 months of dialysis. Seven (53.8%) of the NSA+ patients had 11 exit-site infections (ESI) and one episode of peritonitis (0.42 total infections/patient-year) due to SA. The 8 patients without SA nasal carriage (NSA-) received dialysis for 6.4 patient-years. None of the NSA-patients had an ESI or peritonitis with SA. Finally, the incidence of non-SA infections in the NSA+ and NSA- groups was not different (0.62 vs 0.31 total infections/patient-year, p > 0.05). In conclusion, there appears to be an association between SA nasal carriage and SA ESI in children on PD. The risk of SA peritonitis in NSA+ patients treated with mupirocin may be minimal. The risk of SA nasal carriage may increase with time on dialysis.

摘要

在接受长期腹膜透析(PD)的儿童中,金黄色葡萄球菌(SA)鼻腔定植的频率以及抗生素治疗的影响尚不清楚。我们在1992年1月至1996年8月期间,对21名接受PD治疗的儿童(平均年龄7.03±5.8岁)每4 - 12周进行一次鼻腔SA培养(总计35.3患者年)。在每种情况下,SA鼻腔定植阳性(NSA +)的患者接受鼻内莫匹罗星治疗7天。在接受透析28.9患者年的13名患者(61.9%)中检测到NSA +。13名患者中有8名(61.5%)在透析的最初3个月内变为NSA +。7名(53.8%)NSA +患者因SA发生了11次出口部位感染(ESI)和1次腹膜炎(每患者年0.42次总感染)。8名无SA鼻腔定植(NSA -)的患者接受透析6.4患者年。NSA -患者中无一例发生SA引起的ESI或腹膜炎。最后,NSA +组和NSA -组中非SA感染的发生率无差异(每患者年总感染率分别为0.62和0.31,p>0.05)。总之,PD儿童中SA鼻腔定植与SA ESI之间似乎存在关联。用莫匹罗星治疗的NSA +患者发生SA腹膜炎的风险可能最小。SA鼻腔定植的风险可能随着透析时间的延长而增加。

相似文献

1
Staphylococcus aureus nasal carriage in children receiving long-term peritoneal dialysis.接受长期腹膜透析的儿童金黄色葡萄球菌鼻腔携带情况。
Adv Perit Dial. 1997;13:281-4.
2
Outcome and clinical implications of a surveillance and treatment program for Staphylococcus aureus nasal carriage in peritoneal dialysis patients.腹膜透析患者金黄色葡萄球菌鼻腔定植监测与治疗项目的结果及临床意义
Adv Perit Dial. 2000;16:271-5.
3
The effectiveness of mupirocin preventing Staphylococcus aureus in catheter-related infections in peritoneal dialysis.莫匹罗星预防腹膜透析导管相关感染中金黄色葡萄球菌的有效性。
Adv Perit Dial. 2000;16:257-61.
4
Lack of correlation between nasal cultures positive for Staphylococcus aureus and the development of S. aureus exit-site infections: results unaffected by routine mupirocin treatment of nasal S. aureus carriage.金黄色葡萄球菌鼻腔培养阳性与金黄色葡萄球菌出口部位感染的发生之间缺乏相关性:结果不受鼻腔金黄色葡萄球菌携带的常规莫匹罗星治疗影响。
Adv Perit Dial. 1994;10:158-62.
5
Intranasal mupirocin does not prevent exit-site infections in children receiving peritoneal dialysis.
Perit Dial Int. 2003 May-Jun;23(3):267-9.
6
The effects of once- or thrice-weekly mupirocin application on mupirocin resistance in patients on continuous ambulatory peritoneal dialysis--first 6 months' experience.持续非卧床腹膜透析患者每周一次或三次应用莫匹罗星对莫匹罗星耐药性的影响——最初6个月的经验
Adv Perit Dial. 2004;20:62-6.
7
[Long-term results of an eradication regime against Staphylococcus aureus in patients treated with peritoneal dialysis].
Nefrologia. 2001 Sep-Oct;21(5):464-70.
8
Staphylococcus aureus CAPD-related infections are associated with nasal carriage.金黄色葡萄球菌腹膜透析相关感染与鼻腔携带有关。
Adv Perit Dial. 1994;10:163-5.
9
The treatment of Staphylococcus aureus nasal carriage in pediatric peritoneal dialysis patients.小儿腹膜透析患者金黄色葡萄球菌鼻腔定植的治疗
Adv Perit Dial. 1994;10:297-9.
10
Effect of once-a-week vs thrice-a-week application of mupirocin on methicillin and mupirocin resistance in peritoneal dialysis patients: three years of experience.莫匹罗星每周一次与每周三次应用对腹膜透析患者耐甲氧西林和耐莫匹罗星情况的影响:三年经验
Ren Fail. 2008;30(4):417-22. doi: 10.1080/08860220801964228.

引用本文的文献

1
Consensus guidelines for the prevention and treatment of catheter-related infections and peritonitis in pediatric patients receiving peritoneal dialysis: 2012 update.小儿腹膜透析患者导管相关感染和腹膜炎预防与治疗的共识指南:2012年更新版
Perit Dial Int. 2012 Jun;32 Suppl 2(Suppl 2):S32-86. doi: 10.3747/pdi.2011.00091.
2
Dialysis-associated peritonitis in children.儿童相关性腹膜炎。
Pediatr Nephrol. 2010 Mar;25(3):425-40. doi: 10.1007/s00467-008-1113-6. Epub 2009 Feb 4.
3
Nasal Staphylococcus aureus carriage is not a risk factor for lower-airway infection in young cystic fibrosis patients.
鼻腔金黄色葡萄球菌携带并非年轻囊性纤维化患者下呼吸道感染的危险因素。
J Clin Microbiol. 2007 Sep;45(9):2979-84. doi: 10.1128/JCM.00855-07. Epub 2007 Jul 25.
4
Continuous peritoneal dialysis in children: a single-centre experience in a developing country.儿童持续性腹膜透析:发展中国家的单中心经验
Pediatr Nephrol. 2006 Mar;21(3):403-7. doi: 10.1007/s00467-005-2090-7. Epub 2005 Dec 29.
5
Merit of the cuff-shaving procedure in children with chronic infection.袖状切除术在儿童慢性感染中的价值。
Pediatr Nephrol. 2004 Nov;19(11):1267-72. doi: 10.1007/s00467-004-1621-y.